| Literature DB >> 30250360 |
Manisha Punia1, Ashok Kumar1, Gaurav Charaya1, Tarun Kumar2.
Abstract
AIM: This study aims to determine the etiology of urinary tract infection (UTI) in dogs and to develop an antibiogram of organisms isolated.Entities:
Keywords: Escherichia coli; Staphylococci; Streptococci; antibiogram; multidrug resistance
Year: 2018 PMID: 30250360 PMCID: PMC6141303 DOI: 10.14202/vetworld.2018.1037-1042
Source DB: PubMed Journal: Vet World ISSN: 0972-8988
Relative frequency of organism isolated from urine samples of dogs suffering from urinary tract infections.
| Bacterial isolates | Number of samples positive | Percent positivity |
|---|---|---|
| 5 | 22.7 | |
| 5 | 22.7 | |
| 4 | 18.18 | |
| 2 | 9.09 | |
| 1 | 4.54 | |
| Mixed infections | 5 | 22.7 |
Streptococci+Klebsiella (1), Streptococci+Escherichiacoli (1), Staphylococcus+Escherichia coli (1), Staphylococcus+Streptococcus (1), Pseudomonas+Escherichia coli (1)
Antimicrobial sensitivity pattern of different bacterial isolates from urine of dogs afflicted with UTI.
| Antimicrobials used | Sensitivity (%) | 95% CI |
|---|---|---|
| Tetracyclines | ||
| Oxytetracycline | 9 (33.33) | 15.55-51.11 |
| Penicillins | ||
| Ampicillin | 11 (40.74) | 22.21-59.27 |
| Amoxicillin | 8 (29.62) | 12.41-46.85 |
| Cloxacillin | 8 (29.62) | 12.41-46.85 |
| Penicillin | 9 (33.33) | 15.55-51.11 |
| Amoxicillin/clavulanic acid | 15 (55.55) | 36.81-74.30 |
| Fluoroquinolones | ||
| Enrofloxacin | 10 (37.03) | 18.82-55.25 |
| Aminoglycosides | ||
| Gentamicin | 19 (70.3) | 53.15-87.59 |
| Amikacin | 13 (48.14) | 29.30-67.00 |
| Neomycin | 15 (55.55) | 36.81-74.30 |
| Streptomycin | 12 (44.44) | 25.70-63.19 |
| Cephalosporins | ||
| Ceftriaxone | 21 (77.77) | 62.10-93.46 |
| Cefoperazone | 19 (70.3) | 53.15-87.59 |
| Ceftriaxone/tazobactam | 24 (88.88) | 77.03-100.74 |
| Macrolides | ||
| Chloramphenicol | 20 (74.07) | 57.54-90.60 |
UTI=Urinary tract infection, CI=Confidence interval
In vitro antibiotic sensitivity pattern of different bacterial isolates.
| Antimicrobials used | Sensitivity (%) | |||||
|---|---|---|---|---|---|---|
| Tetracyclines | ||||||
| Oxytetracycline | 2 (25) | 5 (62.5) | 3 (50) | 1 (33.33) | 0 | 1 (100) |
| Penicillins | ||||||
| Ampicillin | 1 (12.5) | 6 (75) | 2 (33.33) | 0 | 0 | 0% |
| Amoxicillin | 1 (12.5) | 4 (50) | 2 (33.33) | 1 (33.33) | 0 | 0% |
| Cloxacillin | 1 (12.5) | 4 (50) | 2 (33.33) | 0 | 0 | 1 (100) |
| Penicillin | 1 (12.5) | 6 (75) | 2 (33.33) | 0 | 0 | 0 |
| Amoxicillin/clavulanic acid | 3 (37.5) | 7 (87.5) | 3 (50) | 2 (66.67) | 0 | 0 |
| Fluoroquinolones | ||||||
| Enrofloxacin | 2 (25) | 3 (37.5) | 3 (50) | 1 (33.33) | 1 (100) | 0 |
| Aminoglycosides | ||||||
| Gentamicin | 6 (75) | 4 (50) | 4 (66.67) | 3 (100) | 1 (100) | 1 (100) |
| Amikacin | 6 (75) | 1 (12.5) | 3 (50) | 1 (33.33) | 1 (100) | 1 (100) |
| Neomycin | 7 (87.5) | 1 (12.5) | 4 (66.67) | 1 (33.33) | 1 (100) | 0 |
| Streptomycin | 4 (50) | 2 (25) | 3 (50) | 1 (33.33) | 1 (100) | 0 |
| Cephalosporins | ||||||
| Ceftriaxone | 5 (62.5) | 8 (100) | 3 (50) | 3 (100) | 1 (100) | 1 (100) |
| Cefoperazone | 5 (62.5) | 8 (100) | 3 (50) | 1 (33.33) | 1 (100) | 1 (100) |
| Ceftriaxone/tazobactam | 6 (75) | 8 (100) | 5 (83.33) | 3 (100) | 1 (100) | 1 (100) |
| Macrolides | ||||||
| Chloramphenicol | 6 (75) | 8 (100) | 3 (50) | 2 (66.67) | 0 | 1 (100) |
E. coli=Escherichia coli
Determination of multidrugresistant isolates using in vitro sensitivity.
| Bacterial isolates | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antibiotics (1-15) within antibiotic groups (A-G) | A | 1 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | RR | ||||||||||
| B | 2 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | ||||||||||||
| 3 | R | R | R | R | R | R | R | RR | R | R | R | R | R | R | R | R | R | R | R | ||||||||||
| 4 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | ||||||||||
| 5 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | |||||||||||
| C | 6 | R | R | R | R | R | R | R | R | R | R | R | R | ||||||||||||||||
| D | 7 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | |||||||||||
| E | 8 | R | R | R | R | R | R | R | R | ||||||||||||||||||||
| 9 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | |||||||||||||||
| 10 | R | R | R | R | R | R | R | R | R | R | R | R | R | ||||||||||||||||
| 11 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | |||||||||||||
| F | 12 | R | R | R | R | R | R | ||||||||||||||||||||||
| 13 | R | R | R R | R | R | R | R | R | |||||||||||||||||||||
| 14 | R | R | R | ||||||||||||||||||||||||||
| G | 15 | R | R | R | R | R | R | ||||||||||||||||||||||
(A) Tetracyclines (1-Oxytetracycline), (B) Penicillins (2-ampicillin; 3-amoxycillin; 4-cloxacillin; 5-penicillin), (C) Penicillin/β lactamase inhibitor combination (6-amoxycillin/clavulanic acid), (D) Fluoroquinolones (7-enrofloxacin), (E) Aminoglycosides (8-gentamicin; 9-amikacin; 10-neomycin; 11-streptomycin), (F) Cephalosporins (12-ceftriaxone; 13-cefoperazone; 14-ceftriaxone/tazobactum), (G) Macrolides (15-chloramphenicol). R=Resistant, Blank=Sensitive